Name: Wednesday's Final Takeaways: Wegovy Surge & Disney Strength
Uploaded: 2026-05-06T20:58:47.795-05:00
Duration: 5 min 9 s
Description: Marley Kayden highlights how Novo Nordisk (NVO) saw earnings boosted by its Wegovy pill, now making up 65% U.S. prescriptions. Sam Vadas breaks down the Walt Disney (DIS) earnings, pointing to a resilient consumer.

Morning Movers

Opening Bell With Nicole Petallides

Morning Trade Live

Trading 360

Fast Market

Next Gen Investing

The Watch List

Market On Close

Market Overtime

Inside the Mind of a Trader

Your First Trade

The Wrap

Liz Ann Live

Schwab 2026 Outlook

<p>Market on Close is Schwab Network’s signature end-of-day show—live from Wall Street and Chicago—where market intel meets real-time momentum. With Sam Vadas at the NYSE and Marley Kayden anchoring from Chicago HQ, we connect the dots between traders, catalysts, and tomorrow’s opening bell.&nbsp;</p>

Daily insights for every investor

Schwab Network's Newsletters

<p>Marley Kayden highlights how Novo Nordisk (NVO) saw earnings boosted by its Wegovy pill, now making up 65% U.S. prescriptions. Sam Vadas breaks down the Walt Disney (DIS) earnings, pointing to a resilient consumer.</p>

Wednesday's Final Takeaways: Wegovy Surge & Disney Strength

Market News